5085 related articles for article (PubMed ID: 3652030)
21. [Dicarboxylic acids inhibit the growth of keratinocytes in vitro].
Detmar M; Müller R; Stadler R; Orfanos CE
Hautarzt; 1986 Nov; 37(11):625-7. PubMed ID: 3804734
[TBL] [Abstract][Full Text] [Related]
22. The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis.
Schallreuter KU; Wood JM
Biochem Biophys Res Commun; 1986 Apr; 136(2):630-7. PubMed ID: 2423087
[TBL] [Abstract][Full Text] [Related]
23. Hyperpigmentary disorders--mechanisms of action. Effect of azelaic acid on melanoma and other tumoral cells in culture.
Breathnach AS; Robins EJ; Nazzaro-Porro M; Passi S; Picardo M
Acta Derm Venereol Suppl (Stockh); 1989; 143():62-6. PubMed ID: 2672685
[TBL] [Abstract][Full Text] [Related]
24. Calcium regulates thioredoxin reductase in human metastatic melanoma.
Schallreuter KU; Wood JM
Biochim Biophys Acta; 1989 Aug; 997(3):242-7. PubMed ID: 2765562
[TBL] [Abstract][Full Text] [Related]
25. Effect of dicarboxylic (C6 and C9) acids on a human squamous carcinoma cell line in culture.
Pätzold HC; Breathnach AS; Robins EJ; Daridan ME; Bhasin YP; Ethridge LB; Nazzaro-Porro M; Passi S; Picardo M
Histol Histopathol; 1989 Apr; 4(2):167-71. PubMed ID: 2520453
[TBL] [Abstract][Full Text] [Related]
26. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors.
U-Taniguchi Y; Furuke K; Masutani H; Nakamura H; Yodoi J
Oncol Res; 1995; 7(3-4):183-9. PubMed ID: 8555652
[TBL] [Abstract][Full Text] [Related]
27. Thioredoxin reductase induction coincides with melanin biosynthesis in brown and black guinea pigs and in murine melanoma cells.
Schallreuter KU; Lemke KR; Hill HZ; Wood JM
J Invest Dermatol; 1994 Dec; 103(6):820-4. PubMed ID: 7528241
[TBL] [Abstract][Full Text] [Related]
28. Karyotype modifications in human malignant melanoma cell cultures after treatment with azelaic acid.
Grammatico P; Scarpa S; Picardo M; Steindl K; Nazzaro-Porro M; Del Porto G
Mutat Res; 1993 Jul; 300(2):119-23. PubMed ID: 7685492
[TBL] [Abstract][Full Text] [Related]
29. EF-hands calcium binding regulates the thioredoxin reductase/thioredoxin electron transfer in human keratinocytes.
Schallreuter KU; Pittelkow MR; Wood JM
Biochem Biophys Res Commun; 1989 Aug; 162(3):1311-6. PubMed ID: 2475107
[TBL] [Abstract][Full Text] [Related]
30. New insights into the anti-inflammatory and anti-melanoma mechanisms of action of azelaic acid and other Fusarium solani metabolites via in vitro and in silico studies.
Ismail M; Hassan MHA; Mohamed EIA; Azmy AF; Moawad A; Mohammed R; Zaki MA
Sci Rep; 2024 Jun; 14(1):14370. PubMed ID: 38909081
[TBL] [Abstract][Full Text] [Related]
31. Validity of the 'bioassay' for thioredoxin-reductase activity.
Fuchs J
Arch Dermatol; 1988 Jun; 124(6):849-51. PubMed ID: 3377515
[No Abstract] [Full Text] [Related]
32. Effects of dicarboxylic acids on normal and malignant melanocytes in culture.
Hu F; Mah K; Teramura DJ
Br J Dermatol; 1986 Jan; 114(1):17-26. PubMed ID: 3942687
[TBL] [Abstract][Full Text] [Related]
33. New effective azelaic acid liposomal gel formulation of enhanced pharmaceutical bioavailability.
Burchacka E; Potaczek P; Paduszyński P; Karłowicz-Bodalska K; Han T; Han S
Biomed Pharmacother; 2016 Oct; 83():771-775. PubMed ID: 27484346
[TBL] [Abstract][Full Text] [Related]
34. Azelaic acid: potential as a general antitumoural agent.
Breathnach AS
Med Hypotheses; 1999 Mar; 52(3):221-6. PubMed ID: 10362281
[TBL] [Abstract][Full Text] [Related]
35. Azelaic acid.
Nazzaro-Porro M
J Am Acad Dermatol; 1987 Dec; 17(6):1033-41. PubMed ID: 2963038
[TBL] [Abstract][Full Text] [Related]
36. Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies.
Breathnach AS
Cutis; 1996 Jan; 57(1 Suppl):36-45. PubMed ID: 8654129
[TBL] [Abstract][Full Text] [Related]
37. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders.
Fitton A; Goa KL
Drugs; 1991 May; 41(5):780-98. PubMed ID: 1712709
[TBL] [Abstract][Full Text] [Related]
38. Free radical reduction by thioredoxin reductase at the surface of normal and vitiliginous human keratinocytes.
Schallreuter KU; Pittelkow MR; Wood JM
J Invest Dermatol; 1986 Dec; 87(6):728-32. PubMed ID: 2431070
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic activity of azelaic acid against human melanoma primary cultures and established cell lines.
Zaffaroni N; Villa R; Silvestro L; Sanfilippo O; Silvestrini R
Anticancer Res; 1990; 10(6):1599-602. PubMed ID: 2285231
[TBL] [Abstract][Full Text] [Related]
40. Azelaic acid: mode of action at cellular and subcellular levels.
Galhaup I
Acta Derm Venereol Suppl (Stockh); 1989; 143():75-82. PubMed ID: 2475996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
